This update concerns Jubilant Pharmova. Read the full report at the source below.
Stocks in this story
A routine update for Jubilant Pharmova. Use the price and stock snapshot to gauge how the market is responding.
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at $1.4 bn
BusinessLine · 31 min ago
Interiors & More Limited — Resignation of Director/KMP/SMP
NSE · 38 min ago
Interiors & More Limited — Change in Directors/KMP/SMP/Auditor/RTA
NSE · 38 min ago
Interiors & More Limited — Change in Management
NSE · 43 min ago
Naveen Jindal Group in talks with US, French firms for proposed nuclear projects
BusinessLine · 47 min ago
Inside the legal campaign that freed Gautam Adani from US prosecution
BusinessLine · 1 hr ago
Tata Consultancy Serv LTFive of India’s top-10 most valued firms add ₹1.54 lakh crore in market capitalisation; TCS biggest winner
Upstox · 1 hr ago
Q1 results 2026: Infosys to Eternal among companies to declare Q1 results next week; check full list here
livemint.com · 1 hr ago
Q1 earnings this week: Infosys, Nestle India, Bajaj Auto among 270 companies set to announce results
financialexpress.com · 1 hr ago
Deloitte projects 6.5-6.8% GDP expansion in FY27, growth to strengthen in second half
Economic Times · 42 min ago
Nifty Outlook for July 20: Bank earning determine next move; oil prices jump
CNBC TV18 · 44 min ago
NTPCQ1 Results This Week, July 20-25: Infosys, Paytm, NTPC, Dr Reddys, IndiGo Among 250+ Companies to Announce
Goodreturns · 50 min ago
Sports economy set to nearly double in 10 years; Latino fans to drive one-third of growth: McKinsey
BusinessLine · 58 min ago
Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.